Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.

Shi L, Westwood S, Baird AL, Winchester L, Dobricic V, Kilpert F, Hong S, Franke A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Buckley NJ, Kate MT, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Zetterberg H, Baker S, Morgan BP, Streffer J, Visser PJ, Bertram L, Lovestone S, Nevado-Holgado AJ.

Alzheimers Dement. 2019 Sep 5. pii: S1552-5260(19)35118-0. doi: 10.1016/j.jalz.2019.06.4951. [Epub ahead of print]

2.

miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease.

Ansari A, Maffioletti E, Milanesi E, Marizzoni M, Frisoni GB, Blin O, Richardson JC, Bordet R, Forloni G, Gennarelli M, Bocchio-Chiavetto L; PharmaCog Consortium.

Neurobiol Aging. 2019 Jun 21;82:102-109. doi: 10.1016/j.neurobiolaging.2019.06.005. [Epub ahead of print]

PMID:
31437718
3.

Sleep deprivation and Modafinil affect cortical sources of resting state electroencephalographic rhythms in healthy young adults.

Del Percio C, Derambure P, Noce G, Lizio R, Bartrés-Faz D, Blin O, Payoux P, Deplanque D, Méligne D, Chauveau N, Bourriez JL, Casse-Perrot C, Lanteaume L, Thalamas C, Dukart J, Ferri R, Pascarelli MT, Richardson JC, Bordet R, Babiloni C; PharmaCog Consortium.

Clin Neurophysiol. 2019 Sep;130(9):1488-1498. doi: 10.1016/j.clinph.2019.06.007. Epub 2019 Jul 1.

PMID:
31295717
4.

Central nervous system regeneration is driven by microglia necroptosis and repopulation.

Lloyd AF, Davies CL, Holloway RK, Labrak Y, Ireland G, Carradori D, Dillenburg A, Borger E, Soong D, Richardson JC, Kuhlmann T, Williams A, Pollard JW, des Rieux A, Priller J, Miron VE.

Nat Neurosci. 2019 Jul;22(7):1046-1052. doi: 10.1038/s41593-019-0418-z. Epub 2019 Jun 10.

PMID:
31182869
5.

Genetic and Real-World Clinical Data, Combined with Empirical Validation, Nominate Jak-Stat Signaling as a Target for Alzheimer's Disease Therapeutic Development.

Nevado-Holgado AJ, Ribe E, Thei L, Furlong L, Mayer MA, Quan J, Richardson JC, Cavanagh J, Consortium N, Lovestone S.

Cells. 2019 May 8;8(5). pii: E425. doi: 10.3390/cells8050425.

6.

Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.

Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):49-58. doi: 10.3233/JAD-181016.

PMID:
30958351
7.

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.

Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ.

Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub 2019 Mar 8.

PMID:
30853464
8.

Improving Mouse Models for Dementia. Are All the Effects in Tau Mouse Models Due to Overexpression?

Joel Z, Izquierdo P, Salih DA, Richardson JC, Cummings DM, Edwards FA.

Cold Spring Harb Symp Quant Biol. 2018;83:151-161. doi: 10.1101/sqb.2018.83.037531. Epub 2019 Feb 11.

PMID:
30745408
9.

Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APPSwe/PSEN1M146V transgenic mice.

Medawar E, Benway TA, Liu W, Hanan TA, Haslehurst P, James OT, Yap K, Muessig L, Moroni F, Nahaboo Solim MA, Baidildinova G, Wang R, Richardson JC, Cacucci F, Salih DA, Cummings DM, Edwards FA.

EBioMedicine. 2019 Jan;39:422-435. doi: 10.1016/j.ebiom.2018.12.006. Epub 2018 Dec 13.

10.

Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.

Jovicich J, Babiloni C, Ferrari C, Marizzoni M, Moretti DV, Del Percio C, Lizio R, Lopez S, Galluzzi S, Albani D, Cavaliere L, Minati L, Didic M, Fiedler U, Forloni G, Hensch T, Molinuevo JL, Bartrés Faz D, Nobili F, Orlandi D, Parnetti L, Farotti L, Costa C, Payoux P, Rossini PM, Marra C, Schönknecht P, Soricelli A, Noce G, Salvatore M, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Frisoniand GB; and the PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):15-35. doi: 10.3233/JAD-180158.

PMID:
30400088
11.

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.

Ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Vandenberghe R, Gabel S, Schaeverbeke J, Scheltens P, Blin O, Richardson JC, Bordet R, Wallin A, Eckerstrom C, Molinuevo JL, Engelborghs S, Van Broeckhoven C, Martinez-Lage P, Popp J, Tsolaki M, Verhey FRJ, Baird AL, Legido-Quigley C, Bertram L, Dobricic V, Zetterberg H, Lovestone S, Streffer J, Bianchetti S, Novak GP, Revillard J, Gordon MF, Xie Z, Wottschel V, Frisoni G, Visser PJ, Barkhof F.

Alzheimers Res Ther. 2018 Sep 27;10(1):100. doi: 10.1186/s13195-018-0428-1.

12.

Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.

Albani D, Marizzoni M, Ferrari C, Fusco F, Boeri L, Raimondi I, Jovicich J, Babiloni C, Soricelli A, Lizio R, Galluzzi S, Cavaliere L, Didic M, Schönknecht P, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Bocchio L, Salvatore M, Rossini PM, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Forloni G, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):37-48. doi: 10.3233/JAD-180321.

PMID:
30149449
13.

Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.

Marizzoni M, Ferrari C, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ribaldi F, Rossini PM, Schönknecht P, Salvatore M, Soricelli A, Hensch T, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):3-14. doi: 10.3233/JAD-180152.

PMID:
29914031
14.

Genomes of ubiquitous marine and hypersaline Hydrogenovibrio, Thiomicrorhabdus and Thiomicrospira spp. encode a diversity of mechanisms to sustain chemolithoautotrophy in heterogeneous environments.

Scott KM, Williams J, Porter CMB, Russel S, Harmer TL, Paul JH, Antonen KM, Bridges MK, Camper GJ, Campla CK, Casella LG, Chase E, Conrad JW, Cruz MC, Dunlap DS, Duran L, Fahsbender EM, Goldsmith DB, Keeley RF, Kondoff MR, Kussy BI, Lane MK, Lawler S, Leigh BA, Lewis C, Lostal LM, Marking D, Mancera PA, McClenthan EC, McIntyre EA, Mine JA, Modi S, Moore BD, Morgan WA, Nelson KM, Nguyen KN, Ogburn N, Parrino DG, Pedapudi AD, Pelham RP, Preece AM, Rampersad EA, Richardson JC, Rodgers CM, Schaffer BL, Sheridan NE, Solone MR, Staley ZR, Tabuchi M, Waide RJ, Wanjugi PW, Young S, Clum A, Daum C, Huntemann M, Ivanova N, Kyrpides N, Mikhailova N, Palaniappan K, Pillay M, Reddy TBK, Shapiro N, Stamatis D, Varghese N, Woyke T, Boden R, Freyermuth SK, Kerfeld CA.

Environ Microbiol. 2018 Aug;20(8):2686-2708. doi: 10.1111/1462-2920.14090. Epub 2018 Apr 6.

PMID:
29521452
15.

Interpreting intracorporeal landscapes: how patients visualize pathophysiology and utilize medical images in their understanding of chronic musculoskeletal illness.

Moore AJ, Richardson JC, Bernard M, Sim J.

Disabil Rehabil. 2019 Jul;41(14):1647-1654. doi: 10.1080/09638288.2018.1443162. Epub 2018 Feb 26.

16.

Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study.

Helliwell T, Muller S, Hider SL, Prior JA, Richardson JC, Mallen CD.

BMJ Open. 2018 Feb 3;8(2):e019320. doi: 10.1136/bmjopen-2017-019320.

17.

Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.

Chen Y, Zhen W, Guo T, Zhao Y, Liu A, Rubio JP, Krull D, Richardson JC, Lu H, Wang R.

PLoS One. 2017 Dec 18;12(12):e0189380. doi: 10.1371/journal.pone.0189380. eCollection 2017.

18.

Brain Networks are Independently Modulated by Donepezil, Sleep, and Sleep Deprivation.

Wirsich J, Rey M, Guye M, Bénar C, Lanteaume L, Ridley B, Confort-Gouny S, Cassé-Perrot C, Soulier E, Viout P, Rouby F, Lefebvre MN, Audebert C, Truillet R, Jouve E, Payoux P, Bartrés-Faz D, Bordet R, Richardson JC, Babiloni C, Rossini PM, Micallef J, Blin O, Ranjeva JP; Pharmacog Consortium.

Brain Topogr. 2018 May;31(3):380-391. doi: 10.1007/s10548-017-0608-5. Epub 2017 Nov 23.

PMID:
29170853
19.

What is the impact of giant cell arteritis on patients' lives? A UK qualitative study.

Liddle J, Bartlam R, Mallen CD, Mackie SL, Prior JA, Helliwell T, Richardson JC.

BMJ Open. 2017 Aug 23;7(8):e017073. doi: 10.1136/bmjopen-2017-017073.

20.

A peculiar mechanism of bite-force enhancement in lungless salamanders revealed by a new geometric method for modeling muscle moments.

Deban SM, Richardson JC.

J Exp Biol. 2017 Oct 1;220(Pt 19):3588-3597. doi: 10.1242/jeb.165266. Epub 2017 Aug 7.

21.

Ongoing Electroencephalographic Activity Associated with Cortical Arousal in Transgenic PDAPP Mice (hAPP V717F).

Del Percio C, Drinkenburg W, Lopez S, Limatola C, Bastlund JF, Christensen DZ, Pedersen JT, Forloni G, Frasca A, Noe FM, Bentivoglio M, Fabene PF, Bertini G, Colavito V, Dix S, Ferri R, Bordet R, Richardson JC, Babiloni C.

Curr Alzheimer Res. 2018;15(3):259-272. doi: 10.2174/1567205014666170704113405.

PMID:
28675996
22.

Where does good quality qualitative health care research get published?

Richardson JC, Liddle J.

Prim Health Care Res Dev. 2017 Sep;18(5):515-521. doi: 10.1017/S1463423617000251. Epub 2017 May 8.

PMID:
28478777
23.

Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).

Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, Albani D, Bartres-Faz D, Didic M, Farotti L, Parnetti L, Salvadori N, Müller BW, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Payoux P, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

Neurobiol Aging. 2017 May;53:1-10. doi: 10.1016/j.neurobiolaging.2017.01.013. Epub 2017 Jan 18.

PMID:
28189924
24.

Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.

Waldron AM, Wyffels L, Verhaeghe J, Richardson JC, Schmidt M, Stroobants S, Langlois X, Staelens S.

J Alzheimers Dis. 2017;55(4):1537-1548. doi: 10.3233/JAD-160760.

25.

On-going electroencephalographic rhythms related to cortical arousal in wild-type mice: the effect of aging.

Del Percio C, Drinkenburg W, Lopez S, Infarinato F, Bastlund JF, Laursen B, Pedersen JT, Christensen DZ, Forloni G, Frasca A, Noè FM, Bentivoglio M, Fabene PF, Bertini G, Colavito V, Kelley J, Dix S, Richardson JC, Babiloni C; PharmaCog Consortium.

Neurobiol Aging. 2017 Jan;49:20-30. doi: 10.1016/j.neurobiolaging.2016.09.004. Epub 2016 Sep 15.

PMID:
27728831
26.

Conclusive Article: Sorting the Good from the Bad: The Different Approaches to Predict Cognitive Properties of New Symptomatic Drug Candidates for Neurodegenerative Diseases in Early Development.

Deguil J, Auffret A, Schenker E, Aujard F, Lamberty Y, Bartrès-Faz D, Herrero MT, Blin O, Micallef J, Richardson JC, Bordet R.

CNS Neurol Disord Drug Targets. 2016;15(7):837-8. Review. No abstract available.

PMID:
27549168
27.

Editorial: Combining Forces to Improve Alzheimer's Disease Drug Discovery: The Symptomatic Battle.

Deguil J, Auffret A, Schenker E, Aujard F, Lamberty Y, Bartrès-Faz D, Blin O, Micallef J, Richardson JC, Bordet R.

CNS Neurol Disord Drug Targets. 2016;15(7):754-5. Review. No abstract available.

PMID:
27549167
28.

A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.

Richardson JC, Liddle J, Mallen CD, Roddy E, Hider S, Prinjha S, Ziebland S.

BMC Musculoskelet Disord. 2016 Jun 6;17:249. doi: 10.1186/s12891-016-1117-5.

29.

Spatial scale modulates the strength of ecological processes driving disease distributions.

Cohen JM, Civitello DJ, Brace AJ, Feichtinger EM, Ortega CN, Richardson JC, Sauer EL, Liu X, Rohr JR.

Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3359-64. doi: 10.1073/pnas.1521657113. Epub 2016 May 31.

30.

The Effects of Physiological and Methodological Determinants on 18F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model.

Deleye S, Waldron AM, Richardson JC, Schmidt M, Langlois X, Stroobants S, Staelens S.

Mol Imaging. 2016 Feb 11;15. pii: 1536012115624919. doi: 10.1177/1536012115624919. Print 2016.

31.

Show Horse Welfare: Horse Show Competitors' Understanding, Awareness, and Perceptions of Equine Welfare.

Voigt MA, Hiney K, Richardson JC, Waite K, Borron A, Brady CM.

J Appl Anim Welf Sci. 2016 Oct-Dec;19(4):335-52. doi: 10.1080/10888705.2016.1152190. Epub 2016 Mar 30.

PMID:
27029609
32.

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.

Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, Fiedler U, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Parnetti L, Payoux P, Del Percio C, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Intern Med. 2016 Jun;279(6):576-91. doi: 10.1111/joim.12482. Epub 2016 Mar 4.

33.

"Why me? I don't fit the mould … I am a freak of nature": a qualitative study of women's experience of gout.

Richardson JC, Liddle J, Mallen CD, Roddy E, Prinjha S, Ziebland S, Hider S.

BMC Womens Health. 2015 Dec 28;15:122. doi: 10.1186/s12905-015-0277-z.

34.

On-Going Frontal Alpha Rhythms Are Dominant in Passive State and Desynchronize in Active State in Adult Gray Mouse Lemurs.

Infarinato F, Rahman A, Del Percio C, Lamberty Y, Bordet R, Richardson JC, Forloni G, Drinkenburg W, Lopez S, Aujard F, Babiloni C, Pifferi F; IMI project PharmaCog Consortium.

PLoS One. 2015 Nov 30;10(11):e0143719. doi: 10.1371/journal.pone.0143719. eCollection 2015.

35.

Transcranial magnetic stimulation and aging: Effects on spatial learning and memory after sleep deprivation in Octodon degus.

Estrada C, Fernández-Gómez FJ, López D, Gonzalez-Cuello A, Tunez I, Toledo F, Blin O, Bordet R, Richardson JC, Fernandez-Villalba E, Herrero MT.

Neurobiol Learn Mem. 2015 Nov;125:274-81. doi: 10.1016/j.nlm.2015.09.011. Epub 2015 Oct 20.

PMID:
26463507
36.

Mapping patients' experiences from initial symptoms to gout diagnosis: a qualitative exploration.

Liddle J, Roddy E, Mallen CD, Hider SL, Prinjha S, Ziebland S, Richardson JC.

BMJ Open. 2015 Sep 14;5(9):e008323. doi: 10.1136/bmjopen-2015-008323.

37.

Cognitive Impairment After Sleep Deprivation Rescued by Transcranial Magnetic Stimulation Application in Octodon degus.

Estrada C, López D, Conesa A, Fernández-Gómez FJ, Gonzalez-Cuello A, Toledo F, Tunez I, Blin O, Bordet R, Richardson JC, Fernandez-Villalba E, Herrero MT.

Neurotox Res. 2015 Nov;28(4):361-71. doi: 10.1007/s12640-015-9544-x. Epub 2015 Jul 21.

PMID:
26194615
38.

First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.

Cummings DM, Liu W, Portelius E, Bayram S, Yasvoina M, Ho SH, Smits H, Ali SS, Steinberg R, Pegasiou CM, James OT, Matarin M, Richardson JC, Zetterberg H, Blennow K, Hardy JA, Salih DA, Edwards FA.

Brain. 2015 Jul;138(Pt 7):1992-2004. doi: 10.1093/brain/awv127. Epub 2015 May 16.

39.

The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.

Balducci C, Paladini A, Micotti E, Tolomeo D, La Vitola P, Grigoli E, Richardson JC, Forloni G.

J Alzheimers Dis. 2015;46(2):471-82. doi: 10.3233/JAD-150029.

PMID:
25777514
40.

A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology.

Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, Nahaboo Solim MA, Moens TG, Paublete RM, Ali SS, Perona M, Desai R, Smith KJ, Latcham J, Fulleylove M, Richardson JC, Hardy J, Edwards FA.

Cell Rep. 2015 Feb 3;10(4):633-44. doi: 10.1016/j.celrep.2014.12.041. Epub 2015 Jan 22.

41.

Striatum and entorhinal cortex atrophy in AD mouse models: MRI comprehensive analysis.

Micotti E, Paladini A, Balducci C, Tolomeo D, Frasca A, Marizzoni M, Filibian M, Caroli A, Valbusa G, Dix S, O'Neill M, Ozmen L, Czech C, Richardson JC, Frisoni GB, Forloni G.

Neurobiol Aging. 2015 Feb;36(2):776-88. doi: 10.1016/j.neurobiolaging.2014.10.027. Epub 2014 Oct 25.

PMID:
25433456
42.

Dietary (-)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing.

Cox CJ, Choudhry F, Peacey E, Perkinton MS, Richardson JC, Howlett DR, Lichtenthaler SF, Francis PT, Williams RJ.

Neurobiol Aging. 2015 Jan;36(1):178-87. doi: 10.1016/j.neurobiolaging.2014.07.032. Epub 2014 Jul 30.

43.

'Keeping going': chronic joint pain in older people who describe their health as good.

Richardson JC, Grime JC, Ong BN.

Ageing Soc. 2014 Sep;34(8):1380-1396. Epub 2013 Apr 11.

44.

Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, Basal Ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia.

Steele JC, Richardson JC, Olszewski J.

Semin Neurol. 2014 Apr;34(2):129-50. doi: 10.1055/s-0034-1377058. Epub 2014 Jun 25. No abstract available.

PMID:
24963673
45.

Extending the authority for sickness certification beyond the medical profession: the importance of 'boundary work'.

Welsh VK, Sanders T, Richardson JC, Wynne-Jones G, Jinks C, Mallen CD.

BMC Fam Pract. 2014 May 17;15:100. doi: 10.1186/1471-2296-15-100.

46.

Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus.

Tarragon E, Lopez D, Estrada C, Gonzalez-Cuello A, Ros CM, Lamberty Y, Pifferi F, Cella M, Canovi M, Guiso G, Gobbi M, Fernández-Villalba E, Blin O, Bordet R, Richardson JC, Herrero MT.

Neuropharmacology. 2014 Oct;85:206-14. doi: 10.1016/j.neuropharm.2014.05.023. Epub 2014 May 27.

PMID:
24878242
47.

Older People's Perceptions of Remaining Physically Active and Living With Chronic Pain.

Moore AJ, Richardson JC, Sim J, Bernard M, Jordan KP.

Qual Health Res. 2014 Jun;24(6):761-772. Epub 2014 Apr 14.

PMID:
24732999
48.

A review of the effects of hypoxia, sleep deprivation and transcranial magnetic stimulation on EEG activity in humans: challenges for drug discovery for Alzheimer's disease.

Babiloni C, Del Percio C, Lizio R, Infarinato F, Blin O, Bartres-Faz D, Dix SL, Bentivoglio M, Soricelli A, Bordet R, Rossini PM, Richardson JC.

Curr Alzheimer Res. 2014;11(5):501-18. Review.

PMID:
24635844
49.

Behaviour change and social blinkers? The role of sociology in trials of self-management behaviour in chronic conditions.

Ong BN, Rogers A, Kennedy A, Bower P, Sanders T, Morden A, Cheraghi-Sohi S, Richardson JC, Stevenson F.

Sociol Health Illn. 2014 Feb;36(2):226-38. doi: 10.1111/1467-9566.12113.

50.

Ethical issues in the reuse of qualitative data: perspectives from literature, practice, and participants.

Yardley SJ, Watts KM, Pearson J, Richardson JC.

Qual Health Res. 2014 Jan;24(1):102-13. doi: 10.1177/1049732313518373. Epub 2013 Dec 27.

PMID:
24374332

Supplemental Content

Loading ...
Support Center